image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Latest issue now available

Essentra - New acquisition for just 5.3x EBITDA post synergies

November 2023

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • ESNT
  • Price:
  • 167p
Essentra has announced the acquisition of BMP TAPPI, an Italian manufacturer and distributor of caps & plugs for an initial €35.5m (plus up to €3.5m deferred). This family-owned firm is based in Milan and is well-known to Essentra, having been a trading partner for over 20 years; it also has a 60 year history, track record of consistent growth, enjoys strong margins and is well invested with attractive margins. Management guide to BMP TAPPI delivering sales of €13.4m for EBITDA of €4.2m in the current year, equating to an initial EBITDA multiple of 8x, but interestingly guidance post synergies is for EBITDA multiple of an attractive 5.3x. It will be eps enhancing in its first full year with funding from existing debt facilitie ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

author